|
1
|
Her C: Nasopharyngeal cancer and the
Southeast Asian patient. Am Fam Physician. 63:1776–1782.
2001.PubMed/NCBI
|
|
2
|
Lo KW, To KF and Huang DP: Focus on
nasopharyngeal carcinoma. Cancer Cell. 5:423–428. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qin L, Zhang X, Zhang L, et al:
Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis
in nasopharyngeal carcinoma cells. Biochem Biophys Res Commun.
371:531–535. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schoof CR, Botelho EL, Izzotti A and dos
Vasques LR: MicroRNAs in cancer treatment and prognosis. Am J
Cancer Res. 2:414–433. 2012.PubMed/NCBI
|
|
5
|
Lee KM, Choi EJ and Kim IA: microRNA-7
increases radiosensitivity of human cancer cells with activated
EGFR-associated signaling. Radiother Oncol. 101:171–176. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jeong SH, Wu HG and Park WY: LIN28B
confers radio-resistance through the posttranscriptional control of
KRAS. Exp Mol Med. 41:912–918. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tian W, Chen J, He H and Deng Y: MicroRNAs
and drug resistance of breast cancer: basic evidence and clinical
applications. Clin Transl Oncol. Aug 23–2012.(Epub ahead of
print).
|
|
8
|
Kanakkanthara A and Miller JH: MicroRNAs:
novel mediators of resistance to microtubule-targeting agents.
Cancer Treat Rev. 39:161–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qu C, Liang Z, Huang J, et al: MiR-205
determines the radio-resistance of human nasopharyngeal carcinoma
by directly targeting PTEN. Cell Cycle. 11:785–796. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
She Z, Chen S, Lin Y, Yuan J, Pang J and
Li M: SZ-685C preparation method and antitumor application.
Application No: 00810028628.3, Application Date. 2008.6:6
|
|
11
|
Xie G, Zhu X, Li Q, et al: SZ-685C, a
marine anthraquinone, is a potent inducer of apoptosis with
anticancer activity by suppression of the Akt/FOXO pathway. Br J
Pharmacol. 159:689–697. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Gan B, Liu D and Paik JH: FoxO
family members in cancer. Cancer Biol Ther. 12:253–259. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu X, He Z, Wu J, et al: A marine
anthraquinone SZ-685C overrides adriamycin-resistance in breast
cancer cells through suppressing Akt signaling. Mar Drugs.
10:694–711. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hitomi J, Katayama T, Eguchi Y, et al:
Involvement of caspase-4 in endoplasmic reticulum stress-induced
apoptosis and Abeta-induced cell death. J Cell Biol. 165:347–356.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tadros SF, D’Souza M, Zhu X and Frisina
RD: Apoptosis-related genes change their expression with age and
hearing loss in the mouse cochlea. Apoptosis. 13:1303–1321. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
LoPiccolo J, Granville CA, Gills JJ and
Dennis PA: Targeting Akt in cancer therapy. Anticancer Drugs.
18:861–874. 2007.
|
|
17
|
Eke I, Koch U, Hehlgans S, et al: PINCH1
regulates Akt1 activation and enhances radio-resistance by
inhibiting PP1alpha. J Clin Invest. 120:2516–2527. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song MS, Salmena L and Pandolfi PP: The
functions and regulation of the PTEN tumour suppressor. Nat Rev Mol
Cell Biol. 13:283–296. 2012.PubMed/NCBI
|
|
19
|
Li SS, Yang S, Wang S, Yang XM, Tang QL
and Wang SH: Latent membrane protein 1 mediates the resistance of
nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by
activation of the PI3K/Akt signaling pathway. Oncol Rep.
26:1573–1579. 2011.PubMed/NCBI
|
|
20
|
Kraus AC, Ferber I, Bachmann SO, et al: In
vitro chemo- and radio-resistance in small cell lung cancer
correlates with cell adhesion and constitutive activation of AKT
and MAP kinase pathways. Oncogene. 21:8683–8695. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tomoda K, Kubota Y and Kato J: Degradation
of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by
Jab1. Nature. 398:160–165. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oh W, Lee EW, Sung YH, et al: Jab1 induces
the cytoplasmic localization and degradation of p53 in coordination
with Hdm2. J Biol Chem. 281:17457–17465. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wan M, Cao X, Wu Y, et al: Jab1
antagonizes TGF-beta signaling by inducing Smad4 degradation. EMBO
Rep. 3:171–176. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pan Y, Zhang Q, Tian L, et al: Jab1/CSN5
negatively regulates p27 and plays a role in the pathogenesis of
nasopharyngeal carcinoma. Cancer Res. 72:1890–1900. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shackleford TJ, Zhang Q, Tian L, et al:
Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate
Jab1/CSN5 expression in mammary carcinoma cells. Breast Cancer Res.
13:R652011. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang J, Chen F, Li W, et al: 14-3-3ζ
interacts with stat3 and regulates its constitutive activation in
multiple myeloma cells. PLoS One. 7:e295542012.
|
|
27
|
Azijli K, Yuvaraj S, Peppelenbosch MP, et
al: Kinome profiling of non-canonical TRAIL signaling reveals
RIP1-Src-STAT3 dependent invasion in resistant non-small cell lung
cancer cells. J Cell Sci. 125:4651–4661. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen F: JNK dependent Stat3
phosphorylation contributes to Akt activation in response to
arsenic exposure. Toxicol Sci. 129:363–371. 2012. View Article : Google Scholar : PubMed/NCBI
|
